TAMSULOSIN HYDROCHLORIDE | N020579 | SANOFI AVENTIS US LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Amendment to Suitability Petition from Rising Pharma Holdings, Inc. FDA-2026-P-3630 Rising Pharma Holdings, Inc. filed this amendment to suitability petition FDA-2026-P-3630 in response to an FDA information request dated April 20, 2026, providing the reference listed drug product labeling for Flomax and proposed labeling for Tamsulosin Hydrochloride Capsules, USP 0.8 mg, as requir | Suitability | 2026-04-28 | Open | Rising Pharma Holdings |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.